中文名稱:Naproxen Sodium | 英文名稱:Naproxen Sodium |
CAS:26159-34-2 | 品牌: 阿拉丁 |
產(chǎn)地: 上海 | 保存條件: -80℃儲存 |
純度規(guī)格: 10mM in DMSO | 產(chǎn)品類別: 藥靶配體 藥靶配體 |
分子式: C14H13NaO3 | 分子量: 252.24 |
運(yùn)輸條件: 超低溫冰袋運(yùn)輸 | 產(chǎn)品規(guī)格: 1ml |
貨號: N407750 | 是否進(jìn)口: 否 |
中文名:Naproxen Sodium
英文名:Naproxen Sodium
英文別名:RS-3650;sodium (S)-2-(6-methoxynaphthalen-2-yl)propanoate
純度:10mM in DMSO
貨號:N407750
包裝:1ml
Cas號:26159-34-2
存儲溫度:-80℃儲存
產(chǎn)品介紹:
Information
Naproxen Sodium (RS-3650) is a COX inhibitor forCOX-1andCOX-2withIC50of 8.7 μM and 5.2 μM, respectively.
In?vitro
Naproxen is approximately equipotent inhibitor of COX-1 and COX-2 in intact cells with IC50 of 2.2 μg/mL and 1.3 μg/mL, respectively. Naproxen decreases the in vitro LPS-induced PGE2 and TXB2 production in rats and humans with IC50 of 30.7 μM and 79.5 μM for PGE2 inhibition, 72.4 μM and 48.3 μM for TXB2 inhibition, respectively. Naproxen produces concentration-related inhibition of TXB2 production from human platelets and LPS-induced TXB2 production from human mononuclear cells with plC50 values (-log concentration inhibiting TXB2 by 50%) of 5.7 and 6.4, respectively, and exhibits slightly inhibitory selectivity for constitutive and induced COX-2 with IC50 COX-1/IC50 COX-2 of 6.3. Only high concentration of Naproxen can significantly induce apoptosis at 48 hours in HCA-7 colon cancer cells with IC50 of 1.45 mM.
In?vivo
Administration of Naproxen reduces the LPS-induced PGE2 and TXB2 production in vivo in rats with IC50 values of 12.8 μM and 5.9 μM, respectively, which represents that Naproxen is a nonselective COX inhibitor with the log IC50 ratio (COX-2/COX-1) of 0.34. Naproxen displays IC50 of 27 μM for analgesia in a rat model with carrageenan-induced arthritis and IC50 of 40 μM for antipyretics in a yeast-induced fever rat model, while exhibits inhibition of PGE2 with IC50 of 13 μM and TXB2 with IC50 of 5 μM.
Cell?Data
cell?lines:
Concentrations:Dissolved in culture medium, final concentration ~20 mM
Incubation?Time:24 and 48 hours
Powder?Purity:≥99%
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對應(yīng)頁面:https://www.aladdin-e.com/zh_cn/N407750.html
成立日期 | 2009-03-16 (16年) | 注冊資本 | 14130.676萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 生物化工,化學(xué)試劑 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP6年
|
武漢弘德悅欣醫(yī)藥科技有限公司
|
2025-01-23 | |
¥1000 |
VIP12年
|
湖北威德利化學(xué)科技有限公司
|
2025-01-23 | |
詢價 |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2025-01-23 | |
詢價 |
VIP13年
|
武漢福鑫化工有限公司
|
2025-01-23 | |
¥800 |
VIP9年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2025-01-23 | |
詢價 |
VIP3年
|
湖北威德利化學(xué)試劑有限公司
|
2025-01-23 | |
詢價 |
VIP6年
|
武漢裕清嘉衡藥業(yè)有限公司
|
2025-01-23 | |
詢價 |
VIP6年
|
湖北威德利化學(xué)試劑有限公司
|
2025-01-23 | |
¥550 |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2025-01-23 | |
詢價 |
VIP6年
|
武漢鼎信通藥業(yè)有限公司
|
2025-01-23 |